{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:49:12Z","timestamp":1791096552293,"version":"4.1.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.3109\/10428194.2014.907891","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T09:42:57Z","timestamp":1396086177000},"page":"2761-2768","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":49,"title":["A phase I\/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma"],"prefix":"10.1080","volume":"55","author":[{"given":"Andr\u00e9","family":"Goy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Hernandez-Ilzaliturri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Protomastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,5,6]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-369629"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2010.09.003"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23608"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2230"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-189977"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4079"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00028-X"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209147"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","volume":"13","author":"Lovec H","year":"1994","journal-title":"EMBO J"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.787"},{"key":"CIT0011","first-page":"8226","volume":"63","author":"Martinez N","year":"2003","journal-title":"Cancer Res"},{"key":"CIT0012","unstructured":"European public assessment report (EPAR) for Torisel [Internet]. London, UK: European Medicines Agency; 2012. Available from: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl = pages\/medicines\/human\/medicines\/000799\/human_med_001098.jsp&mid = WC0b01 ac058001d124"},{"key":"CIT0013","unstructured":"FDA approves bortezomib (Velcade) for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy [Internet]. Silver Spring, MD: US Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research (CDER); 2006 [updated 2009 May 21]. Available from: http:\/\/www.fda.gov\/AboutFDA\/CentersOffices\/OfficeofMedicalProductsandTobacco\/CDER\/ucm094929.htm"},{"key":"CIT0014","unstructured":"Lenalidomide [Internet]. Silver Spring, MD: US Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research (CDER); 2013. Available from: http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm355438.htm?source=govdelivery"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306220"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl316"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.9665"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.108"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.050"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6789"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2091"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1304105"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4322"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210679"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709443104"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401937"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1232-1"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08669.x"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-130781"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-129833"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-034173"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0999"},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"Cheson BD","year":"1999","journal-title":"J Clin Oncol"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.059"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-137943"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0955"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.109"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5836"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2013.79"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2014.907891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:57:18Z","timestamp":1565315838000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2014.907891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,6]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,6,27]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.3109\/10428194.2014.907891"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2014.907891","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}